Off-Target Networks Derived from Ligand Set Similarity

Methods in Molecular Biology

Volumn 575, Issue , 2009, Pages 195-205

  Keiser, Michael J ^a   Hert, Jérôme ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Expectation value; Off targets; Polypharmacology; SEA; Target network

Indexed keywords

LIGAND; PROTEIN;

ARTICLE; CHEMISTRY; DRUG DEVELOPMENT; FACTUAL DATABASE; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; PROTEIN DATABASE; STATISTICAL MODEL; STATISTICS; STRUCTURAL HOMOLOGY;

DATABASES, FACTUAL; DATABASES, PROTEIN; DRUG DISCOVERY; LIGANDS; MODELS, STATISTICAL; MOLECULAR BIOLOGY; PROTEINS; STRUCTURAL HOMOLOGY, PROTEIN;

MLCS; MLOWN;

EID: 75549085923     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-274-2_8     Document Type: Chapter

References (14)

1. Roth, B., Sheffler, D., and Kroeze, W. (2004) Magic shotguns versus magic bul-lets: Selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3, 353–359.
2. Paolini, G., Shapland, R., van Hoorn, W., Mason, J., and Hopkins, A. (2006) Global mapping of pharmacological space. Nat. Biotechnol. 24, 805–815.
3. Nidhi, Glick, M., Davies, J.W., and Jenkins, J.L. (2006) Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J. Chem. Inf. Model. 46, 1124–1133.
4. Izrailev, S., and Farnum, M.A. (2004) Enzyme classification by ligand binding. Proteins 57, 711–724.
5. Campillos, M., Kuhn, M., Gavin, A.C., Jensen, L.J., and Bork, P. (2008) Drug target identification using side-effect similarity. Science 321, 263–266.
6. Keiser, M., Roth, B., Armbruster, B., Ernsberger, P., Irwin, J., and Shoichet, B. (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197– 206.
7. Johnson, M.A., and Maggiora, G.M. (1990) Concepts and Applications of Molecular Similarity. John Wiley, New York.
8. Frye, S.V. (1999) Structure–activity rela-tionship homology (SARAH): A conceptual framework for drug discovery in the genomic era. Chem. Biol. 6, R3–R7.
9. Jacoby, E., Schuffenhauer, A., and Floer-sheim, P. (2003) Chemogenomics knowl- edge-based strategies in drug discovery. Drug News Perspect. 16, 93–102.
10. Hert, J., Keiser, M., Irwin, J., Oprea, T., and Shoichet, B. Quantifying the relationships among drug classes. J. Chem. Inf. Model 48, 755–765.
11. The MDL Drug Data Report Database is available from MDL Information Sys-tems, Inc. (Accessed at http://www.mdl. com.)
12. Shannon, P., Markielm, A., Ozierm, O., et al. (2003) Cytoscape: A software environ-ment for integrated models of biomolecu-lar interaction networks. Genome Res. 13, 2498–2504.
13. Kruskal, J. (1956) On the shortest spanning subtree and the traveling salesman problem. Proc. Amer. Math. Soc. 7, 48–50.
14. SciPy: Open Source Scientific Tools for Python. (2001) (Accessed at http://www. scipy.org.).